SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11903411
Source:
http://linkedlifedata.com/resource/pubmed/id/11903411
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011860
,
umls-concept:C0017628
,
umls-concept:C0030705
,
umls-concept:C0205177
,
umls-concept:C0229671
,
umls-concept:C0332307
,
umls-concept:C0441889
,
umls-concept:C0870883
,
umls-concept:C1280500
pubmed:issue
6
pubmed:dateCreated
2002-3-20
pubmed:abstractText
To study the effects and serum levels of glibenclamide (Gb) and its active metabolites in patients on chronic Gb medication on different daily doses.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100883645
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose
,
http://linkedlifedata.com/resource/pubmed/chemical/Glyburide
,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin
,
http://linkedlifedata.com/resource/pubmed/chemical/Proinsulin
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1462-8902
pubmed:author
pubmed-author:HallengrenBB
,
pubmed-author:JönssonAA
,
pubmed-author:MelanderAA
,
pubmed-author:RydbergTT
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
403-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11903411-Aged
,
pubmed-meshheading:11903411-Biotransformation
,
pubmed-meshheading:11903411-Blood Glucose
,
pubmed-meshheading:11903411-Diabetes Mellitus, Type 2
,
pubmed-meshheading:11903411-Dose-Response Relationship, Drug
,
pubmed-meshheading:11903411-European Continental Ancestry Group
,
pubmed-meshheading:11903411-Female
,
pubmed-meshheading:11903411-Glyburide
,
pubmed-meshheading:11903411-Hemoglobin A, Glycosylated
,
pubmed-meshheading:11903411-Humans
,
pubmed-meshheading:11903411-Hypoglycemic Agents
,
pubmed-meshheading:11903411-Insulin
,
pubmed-meshheading:11903411-Middle Aged
,
pubmed-meshheading:11903411-Proinsulin
,
pubmed-meshheading:11903411-Sweden
pubmed:year
2001
pubmed:articleTitle
Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes.
pubmed:affiliation
Department of Endocrinology, Lund University, Malmö University Hospital, Malmö, Sweden. anders.joensson@ryhov.ltjkpg.se
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't